The pharmacological and biochemical basis of neuroleptic treatment in schizophrenia
- 1 June 1982
- journal article
- review article
- Published by Springer Nature in International Journal of Clinical Pharmacy
- Vol. 4 (3) , 71-78
- https://doi.org/10.1007/bf01962247
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Development of Psychiatric Illness in Drug AbusersNew England Journal of Medicine, 1979
- Clinical assessment of dopamine receptor blockadeLife Sciences, 1978
- Antipsychotic drug doses and neuroleptic/dopamine receptorsNature, 1976
- Dopamine receptor binding: Differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidolLife Sciences, 1975
- Effect of butaclamol on dopamine-sensitive adenylate cyclase in the rat striatumJournal of Pharmacy and Pharmacology, 1975
- Drugs, Neurotransmitters, and SchizophreniaScience, 1974
- End of a Back Ward: The Rapid Rehabilitation And Release of Chronically Hospitalized Psychiatric PatientsPsychosomatics, 1973
- THE MANAGEMENT OF EXCITEMENT IN A GENERAL HOSPITAL PSYCHIATRIC WARD BY HIGH DOSAGE HALOPERIDOLActa Psychiatrica Scandinavica, 1971
- Mechanism of action of psychomotor stimulant drugsInternational Journal of Neuropharmacology, 1964
- Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatumLife Sciences, 1964